Efficacy of LNS8801 in melanoma patients with prior immune-related adverse events from immune-checkpoint inhibitors

被引:0
|
作者
Cohen, J. V. [1 ]
Garyantes, T. K. [2 ]
Muller, C. [3 ]
Natale, C. A. [4 ]
Orloff, M. [5 ]
Patel, S. [6 ]
Rodon, J. [7 ]
Shoushtari, A. N. [8 ]
机构
[1] Univ Penn, Abramson Canc Ctr, Oncol Dept, Philadelphia, PA 19104 USA
[2] Linnaeus Therapeut, R&D, Haddonfield, NJ USA
[3] Univ New Mexico, Gynecol Oncol, Albuquerque, NM 87131 USA
[4] Linnaeus Therapeut, Res, Haddonfield, NJ USA
[5] Thomas Jefferson Univ Hosp, Med Oncol, Philadelphia, PA 19107 USA
[6] Univ Texas MD Anderson Canc Ctr, Melanoma Med Oncol Dept, Houston, TX 77030 USA
[7] Univ Texas MD Anderson Canc Ctr, Drug Dev Dept, Main Bldg, Houston, TX 77030 USA
[8] MSKCC Mem Sloan Kettering Canc Ctr, Med Dept, New York, NY USA
关键词
D O I
10.1016/j.annonc.2024.08.2140
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1137P
引用
收藏
页码:S746 / S746
页数:1
相关论文
共 50 条
  • [1] Association of immune-related adverse events with immune-checkpoint inhibitors and treatment response in melanoma patients.
    Rodriguez, Benigno
    Martinez-Herrera, Jose Fabian
    Zepeda, Lorena Lopez
    Olivares, Guillermo
    Villalobos, Alberto
    Perez, Fernando
    Limas, Christian Patricio Camacho
    Serrano, Juan Alberto
    Villamayor, Omar Serrano
    Lopez, Ervin Saul Enciso
    Gerson, Daniela Shveid
    Sanchez, Efrain Isaias Camarin
    Molina, Diana Bonilla
    Cabrera, Juan Manuel Tovar
    Nehmad, Cecilia
    Whaley, Juan Jose Juarez -Vignon
    Gerson, Raquel
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [2] Association of efficacy and immune-related adverse events (irAEs) in patients with NSCLC receiving immune-checkpoint inhibitors (ICIs)
    Riudavets Melia, M.
    Gabriela Sullivan, I.
    Barba Joaquin, A.
    Anguera Palacios, G.
    del Carpio, L. P.
    Molto Valiente, C.
    Camacho Arellano, S. D.
    Moron Asensio, S.
    Gomila Pons, P.
    Andres Granyo, M.
    Castillo Villegas, D.
    Facundo Molas, C.
    Garcia Planella, E.
    Gonzalez Blanco, C.
    Barnadas Molins, A.
    Gich Saladich, I.
    Majem Tarruella, M.
    ANNALS OF ONCOLOGY, 2018, 29 : 509 - 509
  • [3] Predictive biomarkers for immune-related adverse events in cancer patients treated with immune-checkpoint inhibitors
    Jingting Wang
    Yan Ma
    Haishan Lin
    Jing Wang
    Bangwei Cao
    BMC Immunology, 25
  • [4] Predictive biomarkers for immune-related adverse events in cancer patients treated with immune-checkpoint inhibitors
    Wang, Jingting
    Ma, Yan
    Lin, Haishan
    Wang, Jing
    Cao, Bangwei
    BMC IMMUNOLOGY, 2024, 25 (01)
  • [5] Predictors of immune-related adverse events and outcomes in patients with NSCLC treated with immune-checkpoint inhibitors
    Serino, M.
    Freitas, C.
    Martins, M.
    Ferreira, P.
    Cardoso, C.
    Veiga, F.
    Santos, V.
    Araujo, D.
    Novais-Bastos, H.
    Magalhaes, A.
    Queiroga, H.
    Fernandes, G.
    Hespanhol, V.
    PULMONOLOGY, 2024, 30 (04): : 352 - 361
  • [6] Immune-Related Adverse Events From Immune Checkpoint Inhibitors
    Marrone, K. A.
    Ying, W.
    Naidoo, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 100 (03) : 242 - 251
  • [7] Safety of thoracic radiotherapy in patients with prior immune-related adverse events from immune checkpoint inhibitors
    Shaverdian, N.
    Beattie, J.
    Thor, M.
    Offin, M.
    Shepherd, A. F.
    Gelblum, D. Y.
    Wu, A. J.
    Simone, C. B., II
    Hellmann, M. D.
    Chaft, J. E.
    Rimner, A.
    Gomez, D. R.
    ANNALS OF ONCOLOGY, 2020, 31 (12) : 1719 - 1724
  • [8] Endocrine immune-related adverse effects of immune-checkpoint inhibitors
    Trevisani, Viola
    Iughetti, Lorenzo
    Lucaccioni, Laura
    Predieri, Barbara
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2023, 18 (05) : 441 - 451
  • [9] Efficacy of immune checkpoint inhibitors in patients with anorectal melanoma in association with immune-related adverse events: a case series
    Yokoyama, Reiko
    Sato, Yasushi
    Nakamura, Fumika
    Kagemoto, Kaizo
    Mitsui, Yasuhiro
    Okamoto, Koichi
    Kawano, Yutaka
    Sogabe, Masahiro
    Miyamoto, Hiroshi
    Takayama, Tetsuji
    CLINICAL JOURNAL OF GASTROENTEROLOGY, 2023, 16 (06) : 842 - 847
  • [10] Efficacy of immune checkpoint inhibitors in patients with anorectal melanoma in association with immune-related adverse events: a case series
    Reiko Yokoyama
    Yasushi Sato
    Fumika Nakamura
    Kaizo Kagemoto
    Yasuhiro Mitsui
    Koichi Okamoto
    Yutaka Kawano
    Masahiro Sogabe
    Hiroshi Miyamoto
    Tetsuji Takayama
    Clinical Journal of Gastroenterology, 2023, 16 (6) : 842 - 847